Epigentek Product Watch: Dec 9, 2010 Premium Amsbio's ExpressArt mRNA amplification kits; Epigentek's EpiSonic 1000 for sample prep; Integrated DNA Technologies' qRT-PCR user guide. New Products: Dec 7, 2010 Premium Olink Genomics' Selector gene panel kits, Integromics' SeqSolve, COSMICv50 release, Epigentek's EpiSonic Multi-Functional Bioprocessor Epigenetics Firm Epigentek Focusing on 'Sixth DNA Base' The Brooklyn-based company has developed technology to identify and quantify 5-hydroxymethylcytosine, which was only identified in mammals a year ago and has been elusive to detection. Product Watch: Jul 1, 2010 Premium SABiosciences' RT2 Profiler PCR Arrays; Finnzymes PCR and qPCR products; Epigentek's MethylFlash Hydroxymethylated DNA Quantification Kit New Products: Mar 9, 2010 Premium Fluidigm's Access Array, COSMIC 46, Galaxy, Epigentek's BisulFlash DNA Modification Kit Mar 9, 2010 Product Watch: Mar 9, 2010 Premium Breaking News Gastric Cancer Chemotherapy Response, Prognoses Predicted With Blood-Based Immune Proteomics International Commission Formed to Expand Molecular Testing Access to Cancer Patients NYU Langone Perlmutter Cancer Center to Validate Biological Dynamics Pancreatic Cancer Test SomaLogic Expands Into Middle East With Proteomics Supply Deal for Group 42 Healthcare Arima Genomics to Offer NGS-Based Gene Fusion Test Through Protean BioDiagnostics CLIA Lab The Scan Drug Response Variants May Be Distinct in Somatic, Germline Samples Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline. Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine. Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures. Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.